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Effects of Common Chemotherapy Drugs on the Human Gut Microbiome
The environment within the human gut contains many types of 
microorganisms, called human gastrointestinal microbiota. 
Throughout recent years, many studies have found a strong 
correlation between the strengths and types of bacteria within the 
human gut microbiome and the overall health of a person. More 
specifically, studies have shown that the bacterial composition of an 
individual’s gut microbiome has an impact on their physiological 
response to chemotherapy. This year we have completed the first two 
phases of our project. We have tested the effect of various 
concentrations of various chemotherapy drugs on the growth of 
human gut microbiota samples and identified and preserved samples 
of interest exhibiting moderate growth and samples without treatment. 
The next phase of the project is to perform DNA extraction upon the 
preserved samples, and DNA sequence the samples to determine 
which specific bacterial species were killed by each specific 
chemotherapy drug. Further examination of these relationships could 





•Send the preserved samples of interest for 16S rRNA sequencing
•Use the results to determine which bacterial species are present in each 
moderate growth well sample and compare it to the bacterial species present 
in the untreated sample
•Examine which specific bacterial species were affected by each 
chemotherapy drug
•Repeat the entire research study using a different donor’s gut microbiota 
sample to ensure replicability and results
•Repeat the entire research study with the addition of probiotics to determine 






When compared to the control group which consists of microbial 
communities with no treatments, we expect that communities exposed to 
chemotherapy drugs will have an alteration of the composition of the 
bacterial species. Specifically, we expect that in high doses of 
chemotherapy drugs certain bacterial species will be exterminated 
resulting in a gradient of microbial growth. We expect that wells with 
moderate microbial growth will have certain species of bacteria that are 
affected by the different kinds of chemotherapy medication. The aim of 
this project is to develop a relationship between specific chemotherapy 
drugs and the specific bacterial species it targets.
Hypothesis
Figure 1 Beta-diversity comparisons of the gut microbiomes of the fecal 
samples collected before chemotherapy and after chemotherapy.
Figure 3. Microbiome and immune response: Diagrammatic representation of 
immunomodulators and bacterial peptides regulating different proteins of the 
cancer cascade
Figure 2. Anaerobic Hood Chamber
• From the results of our trials, the higher concentrations (60-80 
microliters) of the chemotherapy drugs had clear effects on the 
growth of human gut microbial communities and most likely affected 
different bacterial species. 
• We also have concluded that there may be a maximum chemotherapy 
drug concentration level at which a difference in bacterial 
composition is seen, as there was not a significant difference in the 
results seen between the 80 and 100 microliter plates.
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Figure 2. Complex interplay of the gut and tumor microbiome and the 
host immune system
Figure 1. 96-Well Plates Set Up
Figure 3. Experimental Design
**green circles represent where intermediate bacterial growth began**
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